CRMD241220C22000
- 0.30
- 0.000.00%
CorMedix Newsroom
Here's Why We Think CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Looks Fair for the Time Being
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic
CorMedix Inc. (NASDAQ:CRMD) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
While Shareholders of CorMedix (NASDAQ:CRMD) Are in the Black Over 1 Year, Those Who Bought a Week Ago Aren't so Fortunate
Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
Cormedix Analyst Ratings
Express News | CorMedix Inc : RBC Raises Target Price to $11 From $9
Needham Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18
CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript Summary
12 Health Care Stocks Moving In Wednesday's Intraday Session
JMP Securities Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $19
CorMedix Down Over 15%, On Pace for Largest Percent Decrease Since June 2023 -- Data Talk
CorMedix Shares Are Trading Lower. The Company Reported Q3 Financial Results.
CorMedix | 10-Q: Q3 2024 Earnings Report
CorMedix | 8-K: CorMedix Inc. Reports THIRD Quarter AND NINE MONTH 2024 Financial Results and Provides Business Update
CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates
Cormedix Q3 2024 GAAP EPS $(0.05) Beats $(0.14) Estimate, Sales $11.456M Beat $10.839M Estimate
Earnings Flash (CRMD) CORMEDIX Posts Q3 Revenue $11.5M
Express News | CorMedix Q3 Net Income USD -2.8 Million